NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/30/2017
Back to search
Official data from USPTO
BIOCHEMICAL PHARMACOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BIOCHEMICAL PHARMACOLOGY
ST13
US500000077133992Class
41
Filing
77133992
Registration
3304938
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
10/03/2017
Classification
Registered
Trademark type
Word
Nice classes
41
Filing date
03/19/2007
Registration date
10/02/2007
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/30/2017
Last transaction
10/03/2017
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
First use anywhere
01/31/1998
First use in commerce
01/31/1998
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
LOTT, MAUREEN
Law office
M80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ELSEVIER INC.
ELSEVIER DELAWARE INC.
ELSEVIER INC.
Representatives
Shari A. Townsend RELX Group
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Providing on-line publications, namely, journals in the fields of science and biology
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/30/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/30/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/30/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
07/20/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/20/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/02/2016
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/17/2012
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/17/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/17/2012
ES8R
TEAS SECTION 8 RECEIVED
10/02/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/02/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/12/2011
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/22/2010
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
10/02/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/30/2007
ALIE
ASSIGNED TO LIE
08/30/2007
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/20/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
07/20/2007
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/20/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
07/20/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/20/2007
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/20/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/16/2007
GNRT
NON-FINAL ACTION E-MAILED
07/16/2007
CNRT
NON-FINAL ACTION WRITTEN
07/16/2007
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/09/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/29/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/28/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/28/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/28/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/27/2007
GNRT
NON-FINAL ACTION E-MAILED
06/27/2007
CNRT
NON-FINAL ACTION WRITTEN
06/27/2007
DOCK
ASSIGNED TO EXAMINER
06/27/2007
MPMK
NOTICE OF PSEUDO MARK MAILED
03/23/2007
NWAP
NEW APPLICATION ENTERED
03/22/2007
Continuous trademark protection
Get notified about every new filing that threatens BIOCHEMICAL PHARMACOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.